<DOC>
	<DOCNO>NCT00404547</DOCNO>
	<brief_summary>The purpose study investigate effectiveness Alvesco速 ( Ciclesonide ) compare usual asthma care primary care set . Patients history asthma least 6 month , opinion physician , meet clinical requirement treatment inhaled steroid ( ICS ) enrol . They either receive Alvesco速 usual care .</brief_summary>
	<brief_title>Asthma Care With Alvesco速 ( Ciclesonide ) Primary Care Adults - The ACCEPT-study ( BY9010/CA-102 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main inclusion criterion : Written inform consent 18 year old diagnosis asthma least 6 month Clinically stable asthma time study enrollment Clinical requirement treatment ICS outline Canadian Asthma Consensus Guidelines If patient currently ICS , dose must stable 3 month must willing switch Main exclusion criterion : On combination therapy ( ICS + long act beta2agonist ) asthma past 3 month require combination therapy Severe asthma , one asthma exacerbation last 3 month require hospitalization emergency room visit , patient use systemic steroid 3 time past 6 month currently use systemic steroid Mild asthma require short act beta2agonists Patients contraindication ICS therapy Any disease medical condition require clinical evaluation , opinion Primary Care Practitioner may interfere clinical study interfere diagnosis asthma . Pregnancy , breast feeding , intention become pregnant course study lack safe contraception premenopausal woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Alvesco速</keyword>
	<keyword>Ciclesonide</keyword>
</DOC>